{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:45:37Z","timestamp":1772113537143,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ejogrb.2016.03.028","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T00:07:45Z","timestamp":1459555665000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Antiretroviral therapy during pregnancy and risk of preterm birth"],"prefix":"10.1016","volume":"201","author":[{"given":"Louise-Helene","family":"Gagnon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"MacGillivray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo L.","family":"Urquia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Caprara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie E.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Yudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2016.03.028_bib0175","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic 2010. Available at: http:\/\/www.unaids.org\/documents\/20101123_GlobalReport_em.pdf [accessed 04.09.14]."},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0180","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic 2011. Available at: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2011\/20111130_ua_report_en.pdf [accessed 04.09.14]."},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0185","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic 2012. Available at: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf [accessed 04.09.14]."},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0190","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic 2013. Available at: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2013\/gr2013\/unaids_global_report_2013_en.pdf [accessed 04.09.14]."},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0195","unstructured":"Pan American Health Organization. 2012 Progress Report: Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in the Americas. Available at: http:\/\/www.unicef.org\/uruguay\/spanish\/Elimination2012.pdf [accessed 04.09.14]."},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0210","first-page":"2913","article-title":"Combination antiretroviral therapy and duration of pregnancy","volume":"Dec","author":"European Collaborative","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0215","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/00002030-200411190-00019","article-title":"Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe","volume":"18","author":"Thorne","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0220","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/503045","article-title":"Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?","volume":"193","author":"Cotter","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0225","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1468-1293.2008.00520.x","article-title":"Increased rate of prematurity associated with antenatal antiretroviral therapy in a German\/Austrian cohort of HIV-1-infected women","volume":"9","author":"Grosch-Woerner","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0235","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome","volume":"346","author":"Tuomala","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0240","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.qai.0000139398.38236.4d","article-title":"Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy","volume":"38","author":"Tuomala","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0245","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/01.aids.0000253362.01696.9d","article-title":"Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth","volume":"20","author":"Szyld","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0250","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1542\/peds.2006-1123","article-title":"Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989\u20132004","volume":"119","author":"Schulte","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0255","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/651232","article-title":"Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy","volume":"201","author":"Patel","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0260","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-0528.2010.02689.x","article-title":"Antiretroviral therapy and preterm delivery \u2013 a pooled analysis of data from the United States and Europe","volume":"117","author":"Townsend","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1468-1293.2010.00876.x","article-title":"Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data","volume":"12","author":"Rudin","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0270","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/cid\/cis198","article-title":"Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?","volume":"54","author":"Sibiude","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0275","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/infdis\/jis728","article-title":"Combination antiretroviral use and preterm birth","volume":"207","author":"Watts","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0280","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"204","author":"Powis","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0285","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","article-title":"Antiretroviral regimens in pregnancy and breast-feeding in Botswana","volume":"362","author":"Shapiro","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1701-2163(16)35156-8","article-title":"Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study","volume":"34","author":"Boyajian","year":"2012","journal-title":"J Obstret Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0295","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/651233","article-title":"Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection","volume":"201","author":"Kourtis","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0300","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1086\/503049","article-title":"Protease inhibitor use during pregnancy: is there an obstetrical risk","volume":"193","author":"Tuomala","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0305","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jiu393","article-title":"HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction","volume":"211","author":"Papp","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/QAD.0000000000000503","article-title":"Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012","volume":"29","author":"Rough","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0335","unstructured":"United Nations Children's Fund and World Health Organization, Low Birthweight: Country, regional and global estimates. UNICEF, New York, 2004. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/43184\/1\/9280638327.pdf [accessed on 09.08.15]."},{"key":"10.1016\/j.ejogrb.2016.03.028_bib0340","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0002-9378(76)90748-1","article-title":"A standard of fetal growth for the United States of America","author":"Brenner","year":"1976","journal-title":"Am J Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151630118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151630118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:35:54Z","timestamp":1759556154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151630118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":28,"alternative-id":["S030121151630118X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.03.028","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiretroviral therapy during pregnancy and risk of preterm birth","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}